Newsletters and Deep Dive digital magazine
Early-stage clinical data with CanSino Biologics' inhaled COVID-19 vaccine show that it was able to stimulate neutralising antibodies against SARS-CoV-2 at a dose well below that required w
Politicking between China and Canada threatened to slow down development of a coronavirus vaccine from CanSino Biologics, but the company says the project is back on track following regulat
Data from more than 1,000 healthy volunteers dosed with a coronavirus vaccine developed at Oxford University and AstraZeneca suggest the shot is safe and stimulates an immune r
US-based Inovio has become the third biotech to begin clinical development of a vaccine against the COVID-19 coronavirus.
Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
An inside guide to unlocking clinical research in the UK